Trials / Completed
CompletedNCT00265018
HD10 for Early Stages
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,370 (actual)
- Sponsor
- University of Cologne · Academic / Other
- Sex
- All
- Age
- 16 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is designed to find the optimum radiation dose and number of cycles for an ABVD chemotherapy combined with an involved field irradiation. It is to be tested whether the reduction from 4 to 2 cycles of ABVD and/or the reduction of the radiation dose from 30 to 20 Gy is feasible without a loss of efficacy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adriamycin | |
| DRUG | Bleomycin | |
| DRUG | Vinblastine | |
| DRUG | DTIC | |
| RADIATION | 30 Gy IF-RT | |
| RADIATION | 20 Gy IF-RT |
Timeline
- Start date
- 1998-05-01
- Primary completion
- 2003-01-01
- First posted
- 2005-12-13
- Last updated
- 2011-07-29
Source: ClinicalTrials.gov record NCT00265018. Inclusion in this directory is not an endorsement.